Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2025 08:00 ET | Source: Praxis Precision Medicines, Inc.

Praxis AES Wrap-up: Best-in-Class Potential Across Rare Pediatric and Adult Epilepsies

Positive Results in the EMBOLD study of relutrigine showed a 53% placebo-adjusted reduction in seizures (p < 0.0002), 66% increase in motor seizure-free days (p = 0.0340), broad and clinically...
December 08, 2025 08:00 ET | Source: Neurona Therapeutics

Neurona Therapeutics Presents New Long-Term Clinical Data from NRTX-1001 Cell Therapy Trials at 2025 Annual Meeting of the American Epilepsy Society

Neurona Therapeutics Presents New Long-Term Clinical Data from NRTX-1001 Cell Therapy Trials at 2025 Annual Meeting of the American Epilepsy Society
March 20, 2025 15:02 ET | Source: Allsup

Allsup Employment Services Joins United Spinal Association’s Work Readiness Program, Admission Now Open

Belleville, Illinois, March 20, 2025 (GLOBE NEWSWIRE) -- Allsup Employment Services (AES) is collaborating on another successful Work Readiness & Education Program with United Spinal...
December 06, 2024 12:00 ET | Source: Neurona Therapeutics

Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-Resistant Epilepsy Announced at 2024 Annual Meeting of the American Epilepsy Society

Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy Announced at 2024 Annual Meet
July 11, 2024 14:27 ET | Source: Allsup

Allsup Employment Services Expert To Present At United Spinal Association Work Readiness Program

Belleville, Illinois, July 11, 2024 (GLOBE NEWSWIRE) -- Allsup Employment Services (AES) Manager Rachel Deick will be featured as part of the United Spinal Association’s Work Readiness &...
February 22, 2024 17:32 ET | Source: Fluence

Fluence Responds to Misleading Short Seller Report

ARLINGTON, Va., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (“Fluence” or “the Company”) (NASDAQ: FLNC), a leading global provider of energy storage products, services, and optimization...
November 28, 2023 07:00 ET | Source: Praxis Precision Medicines, Inc.

Praxis Precision Medicines to Showcase Largest Pipeline of Precision Epilepsy Programs and Breadth of Commitment to Epilepsy Treatments at Upcoming Meetings

BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
December 16, 2022 05:02 ET | Source: The Insight Partners

At 8% CAGR, Ceramic Fiber Market to Outstrip $2.51 Billion During 2022–2028 | Exclusive Report by The Insight Partners

New York, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Ceramic Fiber Market Size, Share, Industry Trends and Forecast to 2028- COVID-19 Impact and...
November 28, 2022 16:05 ET | Source: Praxis Precision Medicines, Inc.

Praxis Precision Medicines to Present at the American Epilepsy Society 2022 Annual Meeting

BOSTON, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
November 29, 2021 08:00 ET | Source: Praxis Precision Medicines, Inc.

Praxis Precision Medicines to Present Data from Rare Disease Programs at the American Epilepsy Society 2021 Annual Meeting

BOSTON, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...